A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer | MicrobiomeTrials← Back to trialsNCT07217301
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-11-26Est. Completion: 2028-11-01
Enrollment target: 600 participants Locations- St. Bernards Healthcare, Jonesboro, Arkansas, United States
- Memorial Care, Fountain Valley, California, United States
- Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
- Translation Research in Oncology- US, INC (TRIO-US), Torrance, California, United States
- D & H Cancer Research Center, Margate, Florida, United States
- BRCR Global, Tamarac, Florida, United States
- The University of Texas M.D Anderson Cancer Center (MDACC), Houston, Texas, United States
- The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
- Anhui Provincial Cancer Hospital, Hefei, Anhui, China
- Anhui Provincial Hospital, Hefei, Anhui, China
- Peking University People's Hospital, Beijing, Beijing Municipality, China
- Beijing Cancer Hospital, Beijing, Beijing Municipality, China
- Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China
- The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
- The Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Fujian Cancer Hospital, Fuzhou, Fujian, ChinaGuangdong Provincial People's Hospital, Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, ChinaThe Fourth Hospital of Hebei University, Shijiazhuang, Hebei, ChinaHarbin Medical University Cancer Hospital, Harbin, Heilongjiang, ChinaThe First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, ChinaHenan Cancer Hospital, Zhengzhou, Henan, ChinaHenan Provincial People's Hospital, Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaThe Third Xiangya Hospital of Central South University, Changsha, Hunan, ChinaNanjing Drum Tower Hospital, Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital, Nanjing, Jiangsu, ChinaJiangsu Province Hospital, Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaThe First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaLiaoning Cancer Hospital, Shenyang, Liaoning, ChinaShandong Cancer Hospital, Jinan, Shandong, ChinaShanghai Chest Hospital, Shanghai, Shanghai Municipality, ChinaShanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, ChinaThe First Affiliated Hospital of Xi'An Jiaotong University, Xi'an, Shannxi, ChinaSichuan Cancer Hospital, Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University, Chengdu, Sichuan, ChinaThe Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaTianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, ChinaYunnan Cancer Hospital, Kunming, Yunnan, ChinaThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital, Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China